SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-21-023769
Filing Date
2021-10-15
Accepted
2021-10-15 20:00:47
Documents
2
Period of Report
2021-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1358
2 ex_291939.htm EX-24 8094
  Complete submission text file 0001437749-21-023769.txt   11126
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1317 CARLTON AVE SUITE 200 CHARLOTTESVILLE VA 22902
Business Address
LANCHONEY DIANA M (Reporting) CIK: 0001887450 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37942 | Film No.: 211327114